With a 21% yearly share price hike against a 6.3% EPS boost, the market's opinion of the business is rising compared to five years ago. The increase in total shareholder returns suggests improving financial performance over time.
Gainers: •$Okta(OKTA.US)$+15.8% (In reaction to earnings) •$StoneCo(STNE.US)$+12.9% (In reaction to earnings) •$Turning Point Therapeutics(TPTX.US)$+116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025) •$Amylyx Pharmaceuticals(AMLX.US)$+24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
马丁-玛丽埃塔材料股票讨论
这些名字也创下了新高:
$皇家加勒比邮轮(RCL.US)$ 交易价格达到自2021年2月以来从未见过的水平
$味好美(MKC.US)$ 以未见的水平进行交易...
• $美国超微公司(AMD.US)$: BMO Capital从市场表现上调至跑赢大盘——115美元(从100美元起)
• $安诺电子(APH.US)$ : 摩根大通从中性上调至增持-PT $83
• $CDW Corp(CDW.US)$ : 摩根大通从中性上调至增持——200美元(从205美元起)
• $好市多(COST.US)$: 德意志银行上调至持有买入——579港元(从525美元起)
• $新东方(EDU.US)$ : 中金从M上调至跑赢大盘...
• $Okta(OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo(STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics(TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals(AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
• $Ciena(CIEN.US)$: B.Riley 从 “中性” 升级至 “买入” ——PT 67 美元(从 65 美元起)
• $艺康集团(ECL.US)$:瑞士信贷从中性上调至跑赢大盘——195加元(从180美元起)
• $Hersha Hospitality Trust(HT.US)$: 杰富瑞从中性上调至买入——13加元(从11美元起)
• $马丁-玛丽埃塔材料(MLM.US)$: 摩根大通从中性上调至增持——410港元(从420美元起)
• $波特兰通用电气(POR.US)$: 高盛从中性上调至买入——P...
暂无评论